S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 1 033 JPY 1.08% Market Closed
Market Cap: 92.9B JPY
Have any thoughts about
Sosei Group Corp?
Write Note

Sosei Group Corp
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sosei Group Corp
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Other Current Liabilities
ÂĄ4.8B
CAGR 3-Years
28%
CAGR 5-Years
30%
CAGR 10-Years
26%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Current Liabilities
ÂĄ1.3T
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
11%
Daiichi Sankyo Co Ltd
TSE:4568
Other Current Liabilities
ÂĄ140.7B
CAGR 3-Years
41%
CAGR 5-Years
25%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Other Current Liabilities
ÂĄ373.1B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Current Liabilities
ÂĄ150.3B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
14%
Astellas Pharma Inc
TSE:4503
Other Current Liabilities
ÂĄ624.9B
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
92.9B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 330.98 JPY
Undervaluation 22%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Other Current Liabilities?
Other Current Liabilities
4.8B JPY

Based on the financial report for Sep 30, 2024, Sosei Group Corp's Other Current Liabilities amounts to 4.8B JPY.

What is Sosei Group Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
26%

Over the last year, the Other Current Liabilities growth was -32%. The average annual Other Current Liabilities growth rates for Sosei Group Corp have been 28% over the past three years , 30% over the past five years , and 26% over the past ten years .

Back to Top